DKA FINANS ApS

CVR number: 26028906
Slotsmarken 12, 2970 Hørsholm
to@immunolex.com
tel: 45353531

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
Gross profit
Costs of management-13.00-11.00-11.00-14.00-35.92
EBIT-13.00-11.00-11.00-14.00-35.92
Other financial income6 314.00
Other financial expenses- 280.00- 286.00- 106.00- 108.00- 112.64
Pre-tax profit- 293.00- 297.006 197.00- 122.00- 148.56
Net earnings- 293.00- 297.006 197.00- 122.00- 148.56

Assets (kDKK)

201920202023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Short term receivables total
Cash and bank deposits1.001.001.30
Cash and cash equivalents1.001.001.30
Balance sheet total (assets)1.001.001.30

Equity and liabilities (kDKK)

20192020202120222023
Share capital1 125.001 125.001 125.001 125.001 125.00
Retained earnings-10 404.00-10 697.00-10 994.00-4 797.00-4 919.80
Profit of the financial year- 293.00- 297.006 197.00- 122.00- 148.56
Shareholders equity total-9 572.00-9 869.00-3 672.00-3 794.00-3 943.36
Capital loans26.0049.0061.0073.00
Non-current liabilities total26.0049.0061.0073.00
Current owed to group member104.94
Other non-interest bearing current liabilities9 547.009 821.003 611.003 721.003 839.72
Current liabilities total9 547.009 821.003 611.003 721.003 944.66
Balance sheet total (liabilities)1.001.001.30
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.